These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 18841326)
1. Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells. Bernhaus A; Ozsvar-Kozma M; Saiko P; Jaschke M; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T Invest New Drugs; 2009 Oct; 27(5):393-401. PubMed ID: 18841326 [TBL] [Abstract][Full Text] [Related]
2. N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine. Saiko P; Ozsvar-Kozma M; Bernhaus A; Jaschke M; Graser G; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T Int J Oncol; 2007 Nov; 31(5):1261-6. PubMed ID: 17912455 [TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect of resveratrol in pancreatic cancer cells. Cui J; Sun R; Yu Y; Gou S; Zhao G; Wang C Phytother Res; 2010 Nov; 24(11):1637-44. PubMed ID: 21031621 [TBL] [Abstract][Full Text] [Related]
4. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406 [TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines. Bader Y; Hartmann J; Horvath Z; Saiko P; Grusch M; Madlener S; Maier S; Oehler L; Fritzer-Szekeres M; Heller N; Alken RG; Krupitza G; Szekeres T Cancer Lett; 2008 Feb; 259(2):231-9. PubMed ID: 18023527 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Zhou C; Qian W; Ma J; Cheng L; Jiang Z; Yan B; Li J; Duan W; Sun L; Cao J; Wang F; Wu E; Wu Z; Ma Q; Li X Cell Prolif; 2019 Jan; 52(1):e12514. PubMed ID: 30341797 [TBL] [Abstract][Full Text] [Related]
7. A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth. Li J; Zhu J; Melvin WS; Bekaii-Saab TS; Chen CS; Muscarella P J Gastrointest Surg; 2006 Feb; 10(2):207-14. PubMed ID: 16455452 [TBL] [Abstract][Full Text] [Related]
8. The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells. Strouch MJ; Milam BM; Melstrom LG; McGill JJ; Salabat MR; Ujiki MB; Ding XZ; Bentrem DJ Pancreas; 2009 May; 38(4):409-15. PubMed ID: 19142175 [TBL] [Abstract][Full Text] [Related]
9. Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines. Giovannetti E; Mey V; Danesi R; Mosca I; Del Tacca M Clin Cancer Res; 2004 May; 10(9):2936-43. PubMed ID: 15131028 [TBL] [Abstract][Full Text] [Related]
10. Monogalactosyl diacylglycerol, a replicative DNA polymerase inhibitor, from spinach enhances the anti-cell proliferation effect of gemcitabine in human pancreatic cancer cells. Akasaka H; Sasaki R; Yoshida K; Takayama I; Yamaguchi T; Yoshida H; Mizushina Y Biochim Biophys Acta; 2013 Mar; 1830(3):2517-25. PubMed ID: 23174220 [TBL] [Abstract][Full Text] [Related]
11. [Effects of gemcitabine and pemetrexed on the proliferation of pancreatic cancer cell lines BXPC-3 and PANC-1 in vitro]. Zhu ZX; Zhang WM; Jia G; Zhou J Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):149-52. PubMed ID: 20118008 [TBL] [Abstract][Full Text] [Related]
12. Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression. Pandita A; Kumar B; Manvati S; Vaishnavi S; Singh SK; Bamezai RN PLoS One; 2014; 9(9):e107154. PubMed ID: 25197966 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment. Schwarz RE; Donohue CA; Sadava D; Kane SE Cancer Lett; 2003 Jan; 189(1):59-68. PubMed ID: 12445678 [TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer. Bianco C; Giovannetti E; Ciardiello F; Mey V; Nannizzi S; Tortora G; Troiani T; Pasqualetti F; Eckhardt G; de Liguoro M; Ricciardi S; Del Tacca M; Raben D; Cionini L; Danesi R Clin Cancer Res; 2006 Dec; 12(23):7099-107. PubMed ID: 17145834 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model. Vendrely V; Peuchant E; Buscail E; Moranvillier I; Rousseau B; Bedel A; Brillac A; de Verneuil H; Moreau-Gaudry F; Dabernat S Cancer Lett; 2017 Apr; 390():91-102. PubMed ID: 28089829 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Ding XZ; Adrian TE Pancreas; 2002 Nov; 25(4):e71-6. PubMed ID: 12409844 [TBL] [Abstract][Full Text] [Related]
17. {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment. Kunnumakkara AB; Sung B; Ravindran J; Diagaradjane P; Deorukhkar A; Dey S; Koca C; Yadav VR; Tong Z; Gelovani JG; Guha S; Krishnan S; Aggarwal BB Cancer Res; 2010 Nov; 70(21):8695-705. PubMed ID: 20864511 [TBL] [Abstract][Full Text] [Related]
18. Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells. Saiko P; Graser G; Giessrigl B; Steinmann MT; Schuster H; Lackner A; Grusch M; Krupitza G; Jaeger W; Somepalli V; Golakoti T; Fritzer-Szekeres M; Szekeres T Invest New Drugs; 2013 Oct; 31(5):1115-24. PubMed ID: 23943154 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of ATR potentiates the cytotoxic effect of gemcitabine on pancreatic cancer cells through enhancement of DNA damage and abrogation of ribonucleotide reductase induction by gemcitabine. Liu S; Ge Y; Wang T; Edwards H; Ren Q; Jiang Y; Quan C; Wang G Oncol Rep; 2017 Jun; 37(6):3377-3386. PubMed ID: 28440428 [TBL] [Abstract][Full Text] [Related]
20. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine. Gao CC; Xu XL; Li F; Gong BG; Liu S; Cui YQ; Sun HC; Xu PY; Zheng YM; Jiang H Tumour Biol; 2016 Jun; 37(6):7555-64. PubMed ID: 26684804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]